Stockscreener 앱 받기
0.9243
5.03%
0.0443
전일 마감가:
$0.88
열려 있는:
$0.87
하루 거래량:
130.85K
Relative Volume:
0.53
시가총액:
$79.14M
수익:
$324.00K
순이익/손실:
$-82.10M
주가수익비율:
0.4487
EPS:
2.06
순현금흐름:
$-69.18M
1주 성능:
+2.85%
1개월 성능:
+5.03%
6개월 성능:
-5.20%
1년 성능:
-3.72%
1일 변동 폭
$0.87
$0.9426
1주일 범위
$0.8301
$0.9426
52주 변동 폭
$0.75
$1.30
Chimerix Inc Stock (CMRX) Company Profile
명칭
Chimerix Inc
전화
919.806.1074
주소
2505 MERIDIAN PARKWAY, SUITE 100, DURHAM, NC
CMRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| CMRX | 0.9243 | 79.14M | 324.00K | -82.10M | -69.18M | 2.06 |
| VRTX | 450.91 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 749.43 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 589.59 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.94 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 106.93 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Chimerix Inc Stock (CMRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-09-07 | 개시 | CapitalOne | Overweight |
| 2021-04-29 | 개시 | Maxim Group | Buy |
| 2021-04-23 | 재개 | Cowen | Outperform |
| 2021-03-31 | 개시 | Jefferies | Buy |
| 2021-03-31 | 개시 | Wedbush | Outperform |
| 2018-02-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-02-02 | 개시 | H.C. Wainwright | Buy |
| 2016-08-09 | 재확인 | FBR Capital | Mkt Perform |
| 2016-02-23 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2016-02-23 | 재확인 | FBR Capital | Mkt Perform |
| 2016-02-23 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2016-02-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2015-12-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2015-12-28 | 다운그레이드 | FBR Capital | Outperform → Mkt Perform |
| 2015-12-28 | 재확인 | Piper Jaffray | Overweight |
| 2015-12-17 | 개시 | UBS | Buy |
| 2015-10-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2015-09-03 | 개시 | Citigroup | Buy |
| 2015-08-18 | 개시 | FBR Capital | Outperform |
| 2015-08-06 | 재확인 | Brean Capital | Buy |
| 2015-05-11 | 재확인 | Brean Capital | Buy |
| 2015-03-04 | 개시 | Barclays | Overweight |
| 2015-02-12 | 재확인 | Stifel | Buy |
| 2014-12-31 | 재확인 | Brean Capital | Buy |
| 2014-07-08 | 재개 | Brean Capital | Buy |
모두보기
Chimerix Inc 주식(CMRX)의 최신 뉴스
Chimerix (FRA:CXF) Change In Receivables : €-0.13 Mil (TTM As of Sep. 2024) - GuruFocus.com
Wedbush Reiterates Outperform Rating for Chimerix (NASDAQ:CMRX) - Defense World
Chimerix (NASDAQ:CMRX) Given Outperform Rating at Wedbush - MarketBeat
Chimerix, Inc. (NASDAQ:CMRX) Short Interest Update - MarketBeat
Chimerix updates officer severance plan, extends term - Investing.com
Chimerix (NASDAQ:CMRX) Earns Buy Rating from HC Wainwright - MarketBeat
Chimerix (CMRX) Announces Updated Phase 2 Response Assessment of Dordaviprone - StreetInsider.com
Chimerix Cancer Drug Shows 28% Response Rate in Phase 2 Brain Tumor Trial | CMRX Stock News - StockTitan
Wedbush Reaffirms “Outperform” Rating for Chimerix (NASDAQ:CMRX) - Defense World
Chimerix, Inc. (NASDAQ:CMRX) Q3 2024 Earnings Call Transcript - Insider Monkey
Chimerix Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Chimerix (CMRX) Reports Q3 Loss, Lags Revenue Estimates - MSN
Earnings call: Chimerix reports progress and financials for Q3 2024 - Investing.com India
Chimerix Inc (CMRX) Q3 2024 Earnings Call Highlights: Strategic Advancements Amid Financial Challenges - GuruFocus.com
Chimerix Inc (CMRX) Q3 2024 Earnings Call Highlights: Strategic Advancements Amid Financial ... - Yahoo Finance
Chimerix: Q3 Earnings Snapshot - CT Insider
Chimerix Inc (CMRX) Quarterly 10-Q Report - Quartzy
Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update - The Manila Times
Chimerix Q3 Loss Narrows to $22.9M; Phase 3 Trial On Track with $152.4M Cash Reserve | CMRX Stock News - StockTitan
Chimerix Inc (CMRX) Q3 2024: Everything You Need to Know Ahead o - GuruFocus.com
Chimerix (CMRX) Set to Announce Earnings on Thursday - MarketBeat
Chimerix (NASDAQ:CMRX) Share Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
CMRXChimerix, Inc. Latest Stock News & Market Updates - StockTitan
Chimerix (NASDAQ:CMRX) Stock Price Passes Below 200 Day Moving AverageHere's Why - MarketBeat
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - StockTitan
Smallpox Treatment Market to Experience Holistic Expansion - openPR
Chimerix (NASDAQ:CMRX) Share Price Passes Above 200-Day Moving Average – What’s Next? - Defense World
Chimerix (NASDAQ:CMRX) Stock Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Chimerix, Inc. (NASDAQ:CMRX) Shares Sold by Armistice Capital LLC - Defense World
Glioma Market Size was valued ~USD 650 million in 2023 and - openPR
Copart, Inc. (NASDAQ:CPRT) Shares Sold by Xponance Inc. - Defense World
Investor’s Delight: Compass Inc (COMP) Closes Strong at 6.20, Up 0.16 - The Dwinnex
Copart, Inc. (NASDAQ:CPRT) Shares Acquired by Summit Trail Advisors LLC - Defense World
Pacer Advisors Inc. Has $6.38 Million Stock Position in Copart, Inc. (NASDAQ:CPRT) - Defense World
Intech Investment Management LLC Sells 115,103 Shares of C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) - MarketBeat
Providence Capital Advisors LLC Acquires Shares of 61,800 Microchip Technology Incorporated (NASDAQ:MCHP) - MarketBeat
C.H. Robinson Worldwide (NASDAQ:CHRW) Sets New 12-Month High at $105.70 - Defense World
What is COMP’s price-to-sales ratio telling us about the company’s value? - US Post News
Company’s Banking Stock: Dissecting a -38.92% Quarterly Revenue Decline Amid Growth - The InvestChronicle
Investors in cash trouble should check out Cross Country Healthcares, Inc. (CCRN) - SETE News
C.H. Robinson Worldwide Sees Unusually High Options Volume (NASDAQ:CHRW) - MarketBeat
CHRS stock touches 52-week low at $1.01 amid market challenges - Investing.com India
Balance Sheet Insights: Compass Therapeutics Inc (CMPX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Analytical Overview: Coherus Biosciences Inc (CHRS)’s Ratios Tell a Financial Story - The Dwinnex
Davidson Kempner Capital Management LP Acquires Shares of 150,000 C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) - Defense World
Integral Health Asset Management LLC Buys Shares of 275,000 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
A stock that deserves closer examination: Coherus Biosciences Inc (CHRS) - US Post News
Mount Yale Investment Advisors LLC Sells 2,003 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Epoch Investment Partners Inc. Buys 29,098 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Here's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation - Yahoo Finance
Barrow Hanley Mewhinney & Strauss LLC Buys 299,721 Shares of Microchip Technology Incorporated (NASDAQ:MCHP) - Defense World
Chimerix Inc (CMRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Chimerix Inc 주식 (CMRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Andriole Michael T. | PRESIDENT AND CEO |
Aug 08 '24 |
Sale |
0.83 |
1,285 |
1,065 |
462,453 |
| Andriole Michael T. | PRESIDENT AND CEO |
Feb 14 '24 |
Sale |
1.04 |
1,744 |
1,809 |
447,021 |
| LaSpaluto Michelle | CHIEF FINANCIAL OFFICER |
Feb 14 '24 |
Sale |
1.04 |
1,940 |
2,023 |
110,999 |
| Jakeman David | VP OF FINANCE AND ACCOUNTING |
Feb 14 '24 |
Sale |
1.04 |
2,660 |
2,777 |
141,232 |
1.80%
0.42%
자본화:
|
볼륨(24시간):